Science Weekly

Meningitis explained: who is most at risk?

15 min
Mar 18, 20262 months ago
Listen to Episode
Summary

This episode examines a meningitis outbreak in Canterbury, England that killed two students and infected 13 others. Dr. Eliza Gill explains how bacterial meningitis spreads, why university students are particularly vulnerable, and discusses the effectiveness of current vaccination programs.

Insights
  • Meningitis bacteria naturally live in most people's throats without causing harm, but can turn deadly when virulence genes activate
  • University students face higher meningitis risk due to close living conditions, socializing patterns, and potential airway irritants like vaping
  • The MenB vaccine provides imperfect immunity that wanes over time, creating protection gaps for current university-age students
  • Outbreak control relies on rapid antibiotic prophylaxis and contact tracing rather than just vaccination
  • Early meningitis symptoms closely mimic common illnesses like hangovers and flu, making diagnosis challenging
Trends
Growing concern about vaccination gaps in young adult populations born before 2015Potential link between vaping and increased respiratory infection risk under investigationEquity issues emerging around private vaccination access during outbreaksNeed for booster vaccination programs as immunity wanes in childhood vaccine recipients
Companies
UK Health Security Agency
Government agency coordinating the meningitis outbreak response and vaccination program
University of Kent
University where outbreak occurred, with students receiving emergency vaccination program
London School of Hygiene and Tropical Medicine
Academic institution where expert Dr. Eliza Gill works as clinical lecturer
People
Dr. Eliza Gill
Clinical lecturer specializing in infectious disease, main expert interviewed
Madeleine Finlay
Guardian journalist and podcast host presenting the episode
Quotes
"This kind of inflammation in the contained space of the skull with a very delicate brain in it is a really dangerous combination for long term damage and can unfortunately be fatal in around 10% of cases."
Dr. Eliza Gill
"We often see outbreaks actually amongst school students and university students, you know, people we think of in the prime of their health."
Dr. Eliza Gill
"Even a, say 75% reduction in risk that faded by the age of 4 would be overall of benefit at a population level."
Dr. Eliza Gill
Full Transcript
3 Speakers
Speaker A

This is the Guardian. Late on Sunday, news emerged of a meningitis outbreak in the southeast of England among university and school students.

0:00

Speaker B

Hundreds of students are queuing for antibiotics this lunchtime following a meningitis outbreak in Canterbury. A year 13 pupil named by her teacher as Juliet and a 21 year old from the University of Kent have died.

0:21

Speaker A

There have since been an additional 13 confirmed cases, an unusually high number for a bacterial meningitis outbreak. The strain has been identified as MENV and scientists and public health officials are racing to find out how and why so many have been infected.

0:39

Speaker B

The outbreak of invasive meningitis has been linked linked to this nightclub in Canterbury. The popular venue now closed until further notice.

0:56

Speaker A

In the meantime, alongside the offer of antibiotics, the UK Health Security Agency has said it plans to launch a small vaccination program for students who live at the University of Kent's Canterbury campus halls of residence. Right now, most people born before 2015 in the UK won't have been offered the MENB vaccine. But in light of the sad deaths of two young people, questions are being asked about whether this should change. So today, what you need to know about the meningitis outbreak so far from the Guardian, I'm Madeleine Finlay and this is Science Weekly, Doctor Eliza Gill, you're a clinical lecturer specialising in infectious disease at the London School of Hygiene and Tropical Medicine. First off, what is meningitis?

1:07

Speaker B

So meningitis is essentially catch all term for anything that causes inflammation of the membranes that surround the brain. So the brain is floating in fluid to protect it from bashing against the skull and in that fluid you have the membranes called the meninges and itis just means inflammation. So it's inflammation of these meningeal membranes and it can be caused by anything. It actually doesn't have to be infection, but infections are kind of the ones that we worry about. And those can be bacterial, viral, occasionally fungal and very rarely parasitic. But here, obviously the ones that we are talking about today in Kent is an outbreak of bacterial meningitis. So that's a bacterial infection of the membranes around the brain.

2:05

Speaker A

And how does a bacterial infection of the brain's membranes happen?

2:46

Speaker B

So almost all causes of meningitis, all the bacteria anyway, they normally are bugs that live in our nose and throat. And in most people who carry them, they never cause any issue, they just are hanging out, just living there, part of your kind of flora, as we would call it. And in a small proportion of cases, for reasons we don't really understand, that probably are a combination of bacteria factors and factors about the host. Sometimes those bacteria are able to invade deeper. Usually they would go first to the bloodstream and that's sepsis as we'd cause it. So then we've got bacteria in the blood and that's causing a lot of inflammatory response, a big immune response in the body and making the person quite unwell. And in a proportion of those cases, as the bacteria are whizzing around in the circulation, in the blood, they're going everywhere. They're also obviously passing through the brain. And in a proportion of cases, they then cross over from the vessels in the meninges into the meningeal spaces and cause meningitis as well. The there's a variety of reasons why that's particularly problematic. So this kind of inflammation in the contained space of the skull with a very delicate brain in it is a really dangerous combination for long term damage and can unfortunately be fatal in around 10% of cases.

2:51

Speaker A

And as you said, this outbreak was caused by a type of bacterial meningitis. We now know Meningitis B. But one of the things that occurred to me was that it's been estimated that up to 1 in 4 young people and 1 in 10 of the general population carry meningitis bacteria in their throats and in their nasal passages passages. And yet only very rarely does an event like this happen. So what causes it to turn from something that's generally innocuous to something that can be very quickly potentially fatal?

4:01

Speaker B

Yes, it's an absolutely fascinating question and one that we don't really have a complete understanding of. So it's probably likely that this particular bacteria that has caused this outbreak has turned on some of its virulence genes. So it's particularly expressing a lot of the molecules, molecules that cause host damage and enable it to become invasive. So within Type B there are also strains. So it's not that all type Bs are the same and we don't have that level of information at the moment. And I'm sure UKHSA are doing a huge amount of work at the moment to understand exactly what this Menga coccus looks like, as in what genes it has, if we've seen it before in the uk, has it caused outbreaks before? So there's going to be bacteria factors that they're going to be looking for to try and understand why this outbreak has happened with Men B. Because as you say, Men B is around in the community and in the majority of cases it doesn't do this. It doesn't normally invade and it doesn't normally cause outbreaks. But it does happen from time to time.

4:32

Speaker A

We often see outbreaks actually amongst school students and university students, you know, people we think of in the prime of their health. So why is it that that's the groups that you often see these outbreaks pop up in?

5:40

Speaker B

We know that university students and sixth formers. It's a time of life where people are often living in very close proximity, they're often socializing a lot, they study and they go out, for example, to this nightclub that we know has been implicated potentially as being involved in the outbreak. And historically, when we think about outbreaks of meningococcus, we look for what have been termed kissing contacts or people that can have close contacts who may have had oral fluid exchanges in, they've been very close, talking to each other or had int contact with each other or shared a small space for a long period of time. So it's just a phase of life where I guess your risk of picking up carriage is higher and then the number of invasive events becomes higher, even though the rate remains very low. It's also worth just discussing because it's coming up sometimes is around vaping. And that question about anything that inflames your airway probably does also increase the background risk of invasion by your respiratory flora, so by the bugs in your throat. And we don't have any evidence at the moment to implicate vaping in this outbreak or sharing vapes, which again I would not recommend because it's obviously an easy way to transmit bacteria. But that will definitely be something that will be considered when people investigate this outbreak, whether vape sharing was implicated and also whether vaping is a risk factor for acquiring invasive meningococcus.

5:54

Speaker A

Now, in the uk babies get a host of vaccines which help protect them against meningitis, including now the Men B vaccine which was introduced in 2015. And then later teenagers were offered a vaccine against four types of bacteria that can cause meningitis, meningococcal groups A, C, W and Y. But how effective are these vaccines?

7:18

Speaker B

So they're not all the same. A MEN B vaccine is known to give imperfect immunity. So even initially the protection is not totally complete. And that immunity also is known to wane over time. And that was accepted when they brought it into the baby schedule because the risk is highest really early in infancy and into sort of toddlerhood, but then falls away quite quickly. And it was ultimately decided that Even a, say 75% reduction in risk that faded by the age of 4 would be overall of benefit at a population level. But when people have looked sort of done similar calculation in adolescence to date, the conclusion has been that it wouldn't be at a population level. A useful thing to do. I'm very sure that that decision will be revisited. The number of cases of meningitis has fallen enormously since we brought in the ACWY vaccine and then even further since MENB came in. For babies in general, babies are at more risk of men B than young adults. So we're now talking about a proportion of a very small number, which is part of the difficulty with making a case for rolling out MENB vaccination because the absolute number of young adults affected is very small. Although obviously it's tragic that anyone is affected by this illness and obviously very sad that we've had two fatalities in this outbreak.

7:41

Speaker A

Unfortunately for the current cohort of university students, they are unlikely to have had the MENBI vaccine. But for those who have had it as babies, will they have protection when they're teenagers?

9:06

Speaker B

Yes, we obviously learn a lot about vaccines by using them. And children born in 2015 will only be 11 at present, so we don't know honestly as to the extent of protection that those children will still have by the time they go to university. And again, whether a booster dose gets added to the vaccine schedule, there won't be any evidence yet to inform that decision making. So it is quite a difficult weighing up on the basis of kind of gut feel and probability without another country to look to at the moment, because we went first.

9:18

Speaker A

Coming up, what you need to know about protecting yourself and others.

9:58

Speaker C

Chicago 2011. A cop is murdered. Police and prosecutors swear they have the trigger man. He swears he didn't do it. How far will each side go to prove they're right?

10:10

Speaker B

Like it's just one bombshell after another.

10:22

Speaker A

You know, you're like, what? What?

10:25

Speaker C

The story of a PlayStation, a brain eating amoeba and the relentless pursuit of justice. Off duty. Out now. Listen, wherever you get your podcasts,

10:27

Speaker A

Eliza. The MENB vaccine is being brought in for outbreak control for the students at the Canterbury campus. And of course antibiotics are on offer for them too. And then there's been contact tracing for those who have been affected. Would you say now it's likely that this outbreak is under control?

10:43

Speaker B

I don't think we can call it under control until we start seeing no further cases. So at the moment, I think there's still a lot of moving parts and unknowns, but I would say the response obviously has been very large scale and since it has begun, has been very quick. And they clearly are offering prophylaxis with antibiotics to a huge number of people. This is not a bug that we typically would worry about. Antibiotic resistance, for example, that isn't at play here. So the antibiotics we would expect to be effective very quickly in clearing the carriage from the throat. So people, if they have been contacted to attend for antibiotics or are aware that they're a contact of a case, should definitely go and take up that offer because that's the best thing they can do to reduce their risk.

10:59

Speaker A

The students at the University of Kent will of course be very aware of any symptoms or potential symptoms of meningitis. And these can be so easily confused with other things like a bad cold or a hangover at the early stages. Public health information is clearly very important in that kind of situation. Do you think right now at risk groups receive enough information about meningitis?

11:43

Speaker B

Yes, I do. To be honest, I think that there is an overwhelming amount of health information available, which sometimes means it's hard to work out what to prioritise for the public. A lot of the symptoms of meningitis and sepsis are similar. They can be very non specific and it is very difficult because many of these students will have had freshers, flu hangovers, a myriad of respiratory illnesses, and it's not straightforward to disentangle meningococcal sepsis or meningitis from those other illnesses. That said, outside of this outbreak situation, it's still most likely to be something else. But if people are concerned, then they should either call 111 if they're outside the outbreak area and get some advice, or if they're obviously in their outbreak area, go and get themselves checked over. And just to reiterate in case anyone isn't familiar, specific symptoms of meningitis that people should be looking out for are things like headache, high fever, neck stiffness, eyes that are bothered by light, a rash that doesn't blanch if you press it with a glass, and then there's non specific symptoms like nausea and vomiting, feeling generally very unwell. Sometimes people have very cold hands and feet or flu like symptoms. So obviously if people have symptoms which they think are meningitis, like, they should get assessed immediately by a healthcare provider.

12:10

Speaker A

And there will be parents thinking of their teenagers right now who might be wondering, you know, oh, should I pay for my child to be privately vaccinated? Is that something worth considering?

13:32

Speaker B

So at an individual level, there's no reason not to have the vaccine if that is something people wish to pursue. Although, as I've said, the actual risk to any one individual is very low. You know, it's a difficult situation at the moment, as you say, because parents that are able to pay are very likely to. And then we have a problem around the equity of access to this vaccine. But clearly, at an individual level, if you are a parent and worried and have the means to vaccinate, I don't think that's a bad decision. I equally don't think people need to be rushing outside of the outbreak area to get themselves vaccinated because the risk remains very low.

13:44

Speaker A

Eliza, thank you so much for coming and explaining all of that.

14:23

Speaker B

Thanks very much.

14:27

Speaker A

Thanks again to Dr. Eliza Gill. This episode was produced by me, Madeline Findlay and Ellie Sands. It was sound designed by Joel Cox, and the executive producer is Ellie Burie. We'll be back next week. See you then.

14:29

Speaker B

This is the Guardian.

14:53